VanizemTM Aframomum melegueta Targets Endocannabinoid System to Provide Clinically Demonstrated Benefits in as Little as 3 Days MORRISTOWN, N.J. , July 25, 2024 /PRNewswire/ -- PLT Health Solutions announced today that it is adding to its industry-leading cognitive health portfolio in North America with a novel botanical ingredient that has been clinically demonstrated to reduce stress, enhance mood and happiness and improve sleep and waking outcomes.
Called VanizemTM, the ingredient is a proprietary selection and extraction of the West African flowering plant Aframomum melegueta (Grains of Paradise) with standardized bioactives. In a recently completed clinical study, Vanizem was shown to provide improvements in self-reported tension scores (POMS) and significant improvements in sleep quality score (LSEQ) along with improvements in mood, vigor, ease of falling asleep and easier morning awakening. The ingredient was introduced to European markets by PLT innovation partner Nektium Pharma (Las Palmas, Spain ) in March of this year.
PLT Health Solutions is the exclusive sales and marketing partner for Vanizem in North America . According to Devin Stagg , Chief Operating Officer for PLT Health Solutions, Vanizem represents a unique approach and opportunity for consumer products companies in the fast growing cognitive health market. "There is no doubt that cognitive health – particularly when it comes to stress, mood and sleep – has captured consumers' attention at every age d.